Literature DB >> 13629473

Clinical experience with imipramine (G22355) in the treatment of depression.

A M MANN, A S MACPHERSON.   

Abstract

Entities:  

Keywords:  DEPRESSION/therapy; TRANQUILIZING AGENTS/therapeutic use

Mesh：

Substances：

Year:  1959        PMID： 13629473     DOI： 10.1177/070674375900400111

Source DB:  PubMed          Journal:  Can Psychiatr Assoc J        ISSN： 0008-4824


× No keyword cloud information.
  13 in total

1.  Toxicity of imipramine: report on serious side effects and massive overdosage.

Authors:  A M MANN; A G CATTERSON; A S MACPHERSON
Journal:  Can Med Assoc J       Date:  1959-07-01       Impact factor: 8.262

2.  A controlled trial of imipramine in treatment of depressive states.

Authors:  J R BALL; L G KILOH
Journal:  Br Med J       Date:  1959-11-21

3.  Antidepressant discontinuation reactions.

Authors:  P Haddad; M Lejoyeux; A Young
Journal:  BMJ       Date:  1998-04-11

4.  The Desmethyl Metabolite of Imipramine (G-35020) in the Treatment of Depression: Further Clinical Experience.

Authors:  A M Mann; G F Heseltine
Journal:  Can Med Assoc J       Date:  1963-06-01       Impact factor: 8.262

Review 5.  Withdrawal phenomena associated with antidepressant and antipsychotic agents.

Authors:  S C Dilsaver
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

6.  Imipramine (tofranil) in mental health clinic and private practice.

Authors:  B V EARLE; A M EARLE
Journal:  Can Med Assoc J       Date:  1960-10-08       Impact factor: 8.262

7.  Home treatment of depression with imipramine (tofranil).

Authors:  E J CLEVELAND; F R TOWNSEND
Journal:  Can Med Assoc J       Date:  1960-09-03       Impact factor: 8.262

8.  Desmethylimipramine (G-35020) in the treatment of depression, pilot study in a general hospital and outpatient setting.

Authors:  A M MANN
Journal:  Can Med Assoc J       Date:  1962-03-17       Impact factor: 8.262

9.  [ON THE METHODOLOGY OF RESEARCH ON ANTIDEPRESSIVE DRUGS WITH SPECIAL REFERENCE TO IMIPRAMINE (TOFRANIL) AND DESMETHYLIMIPRAMINE (PERTOFRAN)].

Authors:  H J HAASE; H KOESTER; M KOENIG; A BLEKER
Journal:  Arch Psychiatr Nervenkr       Date:  1963-09-18

10.  Withdrawal Symptoms Following Discontinuation of Vortioxetine-Retrospective Chart Review.

Authors:  Marcin Siwek; Adrian Andrzej Chrobak; Aleksandra Gorostowicz; Anna Julia Krupa; Dominika Dudek
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.